Comparative Performance of Three Anti–Factor Xa Heparin Assays in Patients in a Medical Intensive Care Unit Receiving Intravenous, Unfractionated Heparin-Reference-Cited by-同舟云学术

Comparative Performance of Three Anti–Factor Xa Heparin Assays in Patients in a Medical Intensive Care Unit Receiving Intravenous, Unfractionated Heparin

Published:2006-09 Issue:3 Volume:126 Page:416-421
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Lehman Christopher M.,Rettmann Jonathan A.,Wilson Lori W.,Markewitz Boaz A.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/126/3/416/4987924/ajcpath126-0416.pdf

Reference9 articles.

1. Büller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):401S-428S.

2. Rosborough TK. Comparison of anti-factor Xa heparin activity and activated partial thromboplastin time in 2,773 plasma samples from unfractionated heparin-treated patients. Am J Clin Pathol. 1997;108:662-668.

3. Baker BA, Adelman MD, Smith PA, et al. Inability of the activated partial thromboplastin time to predict heparin levels: time to reassess guidelines for heparin assays. Arch Intern Med. 1997;157:2475-2479.

4. Rosborough TK. Monitoring unfractionated heparin therapy with antifactor Xa activity results in fewer monitoring tests and dosage changes than monitoring with the activated partial thromboplastin time. Pharmacotherapy. 1999;19:760-766.

5. Messori A, Vacca F, Vaiani M, et al. Antithrombin III in patients admitted to intensive care units: a multicenter observational study. Crit Care. 2002;6:447-451.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombin Levels and Heparin Responsiveness during Venoarterial Extracorporeal Membrane Oxygenation: A Prospective Single-center Cohort Study;Anesthesiology;2024-01-25

2. Is it time to switch to bivalirudin for ECMO anticoagulation?;Frontiers in Medicine;2023-08-21

3. Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis;Journal of Thrombosis and Haemostasis;2023-02

4. Extracorporeal corporeal membrane oxygenation: indications, technical considerations, and future trends;Annals of Blood;2022-04

5. Anticoagulation in Splanchnic Vein Thrombosis With and Without Underlying Liver Disease;Portal Hypertension VII;2022